-
Novak Djokovic: divisive tennis great on brink of history
-
History beckons for Djokovic and Alcaraz in Australian Open final
-
Harrison, Skupski win Australian Open men's doubles title
-
Epstein offered ex-prince Andrew meeting with Russian woman: files
-
Jokic scores 31 to propel Nuggets over Clippers in injury return
-
Montreal studio rises from dark basement office to 'Stranger Things'
-
US government shuts down but quick resolution expected
-
Mertens and Zhang win Australian Open women's doubles title
-
Venezuelan interim president announces mass amnesty push
-
China factory activity loses steam in January
-
Melania Trump's atypical, divisive doc opens in theatres
-
Bad Bunny set for historic one-two punch at Grammys, Super Bowl
-
Five things to watch for on Grammys night Sunday
-
Venezuelan interim president proposes mass amnesty law
-
Rose stretches lead at Torrey Pines as Koepka makes cut
-
Online foes Trump, Petro set for White House face-to-face
-
Seattle Seahawks deny plans for post-Super Bowl sale
-
US Senate passes deal expected to shorten shutdown
-
'Misrepresent reality': AI-altered shooting image surfaces in US Senate
-
Thousands rally in Minneapolis as immigration anger boils
-
US judge blocks death penalty for alleged health CEO killer Mangione
-
Lens win to reclaim top spot in Ligue 1 from PSG
-
Gold, silver prices tumble as investors soothed by Trump Fed pick
-
Ko, Woad share lead at LPGA season opener
-
US Senate votes on funding deal - but shutdown still imminent
-
US charges prominent journalist after Minneapolis protest coverage
-
Trump expects Iran to seek deal to avoid US strikes
-
US Justice Dept releases documents, images, videos from Epstein files
-
Guterres warns UN risks 'imminent financial collapse'
-
NASA delays Moon mission over frigid weather
-
First competitors settle into Milan's Olympic village
-
Fela Kuti: first African to get Grammys Lifetime Achievement Award
-
Cubans queue for fuel as Trump issues oil ultimatum
-
'Schitt's Creek' star Catherine O'Hara dead at 71
-
Curran hat-trick seals 11 run DLS win for England over Sri Lanka
-
Cubans queue for fuel as Trump issues energy ultimatum
-
France rescues over 6,000 UK-bound Channel migrants in 2025
-
Surprise appointment Riera named Frankfurt coach
-
Maersk to take over Panama Canal port operations from HK firm
-
US arrests prominent journalist after Minneapolis protest coverage
-
Analysts say Kevin Warsh a safe choice for US Fed chair
-
Trump predicts Iran will seek deal to avoid US strikes
-
US oil giants say it's early days on potential Venezuela boom
-
Fela Kuti to be first African to get Grammys Lifetime Achievement Award
-
Trump says Iran wants deal, US 'armada' larger than in Venezuela raid
-
US Justice Dept releases new batch of documents, images, videos from Epstein files
-
Four memorable showdowns between Alcaraz and Djokovic
-
Russian figure skating prodigy Valieva set for comeback -- but not at Olympics
-
Barcelona midfielder Lopez agrees contract extension
-
Djokovic says 'keep writing me off' after beating Sinner in late-nighter
Laser Photonics Receives $1.3 Million Order for Pharmaceutical Tablet Laser Drilling System
Significant Order with New International Pharmaceutical Customer Highlights Company's Growth and Revenue Opportunity
ORLANDO, FLORIDA / ACCESS Newswire / January 22, 2026 / Laser Photonics Corporation (NASDAQ:LASE), a global leader in laser systems for industrial and defense applications, today announced that it has received a $1.3 million order for a CMS Laser Pharmaceutical Tablet Laser Drilling System from a new international pharmaceutical customer.
Laser Photonics' subsidiary CMS Laser engineers fully automated, laser-powered tablet drilling systems for full-scale, high-volume pharmaceutical manufacturing. The new order is for a custom TD-140, designed for single-sided drilling of up to 140,000 circular tablets per hour. The system combines advanced CO2 laser hardware, dual-vision inspection, and an oscilloscope for remote diagnostics to meet the most demanding commercial production environments. CMS Laser's solutions for the medical and pharmaceutical industries incorporate software designed to help customers meet FDA 21 CFR Part 11 requirements related to electronic signatures and audit logs.
Wayne Tupuola, the Chief Executive Officer of Laser Photonics, commented: "This significant order from a new customer will meet demanding production requirements, highlighting our system's precision, reliability, and validation standards in highly regulated manufacturing. CMS Laser provides advanced solutions to pharmaceutical companies around the world, addressing a wide range of pharmaceutical needs, from high-volume tablet drilling and marking to research and development.
"We are accelerating our market position in the high-demand pharmaceutical equipment sector known for its growth and stability, securing new and repeat orders for high-precision applications worldwide. Robust demand and a pipeline of new opportunities are rapidly building momentum for us as we expand our sales and marketing infrastructure, customer engagement, and market reach. We believe we will continue to strengthen revenue and growth in the months to come as we strive to build sustainable shareholder value over the long term."
To learn more about CMS Laser's tablet drilling technology, please visit our blog.
About Laser Photonics Corporation
Laser Photonics Corporation (NASDAQ:LASE) is a global leader in laser systems for industrial and defense applications. The Company develops and manufactures advanced laser technologies used in cleaning, surface preparation, and precision material processing across demanding operating environments. Laser Photonics serves a broad range of end markets, including defense and government, aerospace, energy, maritime, automotive, and advanced manufacturing. Through a combination of internal development, strategic acquisitions, and partnerships, the Company continues to expand its product portfolio and address new applications where performance, efficiency, and environmental considerations are critical. For more information, please visit laserphotonics.com.
Cautionary Note Concerning Forward-Looking Statements
This press release contains forward-looking statements within the meaning of applicable securities laws. These statements are based on current expectations as of the date of this press release and involve risks and uncertainties that may cause results and uses of proceeds to differ materially from those indicated by these forward-looking statements. We encourage readers to review the "Risk Factors" in our Registration Statement for a comprehensive understanding. Laser Photonics Corp. undertakes no obligation to revise or update any forward-looking statements, except as required by applicable laws or regulations, to reflect events or circumstances after the date of this press release.
Investor Relations Contact
Lucas A. Zimmerman & Ian Scargill
MZ Group - MZ North America
(262) 357-2918
[email protected]
www.mzgroup.us
SOURCE: Laser Photonics Corp.
View the original press release on ACCESS Newswire
T.Sanchez--AT